Impact of the food and drug administration safety warnings and removal of indications for use of oral quinolones

被引：0
|
作者：
Tran, Phuong T. [1 ,2 ]
Antonelli, Patrick J. [2 ,3 ]
Hincapie-Castillo, Juan M. [1 ,2 ]
Winterstein, Almut G. [1 ,2 ]
机构：
[1] Univ Florida, Dept Pharmaceut Outcomes & Policy, Coll Pharm, Gainesville, FL USA
[2] Univ Florida, Ctr Drug Evaluat & Safety, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Otolaryngol, Gainesville, FL USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4868
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [41] Examining the Impact of UK Drug Safety Warnings on Antipsychotic Drug Prescribing to Older People with Dementia
    Stocks, Susan J.
    Webb, Roger T.
    Kontopanatelis, Evangelos
    Burns, Alistair
    Ashcroft, Darren M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 262 - 263
  • [42] Impact of safety warnings on drug utilization: Marketplace life span of cisapride and troglitazone
    Wilkinson, JJ
    Force, RW
    Cady, PS
    [J]. PHARMACOTHERAPY, 2004, 24 (08): : 978 - 986
  • [43] Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs
    Garg, Vishvas
    Raisch, Dennis W.
    McKoy, June M.
    Trifilio, Steven M.
    Holbrook, Jamiee
    Edwards, Beatrice J.
    Belknap, Steven M.
    Samaras, Athena T.
    Nardone, Beatrice
    West, Dennis P.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2013, 12 (03) : 299 - 307
  • [44] Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program
    Feit, Noah Z.
    Goldman, Debra A.
    Smith, Evan
    Deighan, Jenny
    Iasonos, Alexia
    Zivanovic, Oliver
    Hyman, David M.
    [J]. JAMA ONCOLOGY, 2019, 5 (04) : 570 - 572
  • [45] Food and Drug Administration Safety Communication on the Use of Transvaginal Mesh in Pelvic Organ Prolapse Repair Surgery: The Impact of Social Determinants of Health
    Mao, Jialin
    Chughtai, Bilal
    Ibrahim, Said
    Sedrakyan, Art
    [J]. FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (01): : E133 - E138
  • [46] Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark
    Hostenkamp, Gisela
    Fischer, Katharina Elisabeth
    Borch-Johnsen, Knut
    [J]. HEALTH POLICY, 2016, 120 (12) : 1404 - 1411
  • [47] Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
    Sankar, Ashwini
    Swanson, Kristi M.
    Zhou, Jiani
    Jena, Anupam Bapu
    Ross, Joseph S.
    Shah, Nilay D.
    Karaca-Mandic, Pinar
    [J]. JAMA NETWORK OPEN, 2021, 4 (12)
  • [48] Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings
    Tucker, Jenna
    Fischer, Tessa
    Upjohn, Laurence
    Mazzera, David
    Kumar, Madhur
    [J]. JAMA NETWORK OPEN, 2018, 1 (06) : e183337
  • [49] US Food and Drug Administration's (FDA) safety assessment of food ingredients
    Thurmond, Scott
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [50] Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety
    Qato, Dima M.
    Alexander, G. Caleb
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14): : 1595 - 1596
12345